Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katharina Stölzel has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Personalised therapy of head and neck cancers – case series at the UKE

    by Katharina Stölzel, Christian Betz, Lukas Wittig, Philippe Breda, Henrike Zech

    The conservative treatment of head and neck cancers (HNC) is undergoing rapid development. Checkpoint inhibitors are already established for advanced/metastatic HNC. Within the framework of our tumour board, the possibility of personalised therapy is increasingly being discussed in the palliative situation. The presentation in the molecular board for the use of the Next Generation Sequencing (NGS) panel, the indication for brachytherapy (after ex vivo radiosensitivity assay) and the application of oncoviruses are therapies that 11 patients with different entities have received at the UKE in the last 3 years. Five patients with salivary gland carcinoma received targeted therapy (palliative), 4 patients with squamous cell carcinoma received brachytherapy (3 palliative, 1 curative), 2 patients received the genetically modified oncovirus talimogene laherparepvec (TVEC) for a mucosal melanoma of the nose (palliative). The results within the group of salivary gland carcinomas show 3x stable disease and 1x progressive disease at follow-up times of 3 months to 3 years. The brachytherapy, which was carried out curatively, showed no indication of local recurrence 12 months after application. Brachytherapy applied to selected patients in first- to third-line palliative therapy had response rates of 75%. The patients on TVEC therapy showed local partial remission 7 months after initiation. However, local side effects forced to pause therapy in one of the two cases. The possibilities of personalised therapy are rapidly increasing showing benefits to selected patients. The challenge remains of applying personalized therapy in a meaningful and cost-covering way. Article published online: 12 May 2023 Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Die Drehstuhluntersuchung in der vestibulären Diagnostik

    by Samira Ira Zabaneh, Katharina Stölzel, Heidi Olze, Steffen Dommerich

    Mit der konzentrischen Rotation auf dem Drehstuhl wird die Funktion der horizontalen Bogengänge untersucht. Damit diese in Drehrichtung ausgerichtet sind, wird der Kopf des/der sitzenden Proband*in um 30° nach unten geneigt. Die Untersuchung wird zunächst im Dunkeln (VNG-Brille mit geschlossenem Visier) durchgeführt. Article published online: 03 August 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Methods for Testing the Subjective Visual Vertical during the Chronic Phase of Menière’s Disease

    by Samira Ira Zabaneh, Linda Josephine Voss, Agnieszka J. Szczepek, Heidi Olze, Katharina Stölzel

    The subjective visual vertical (SVV) evaluates the function of the utricle, which, in patients with Menière’s disease (MD), can be affected by endolymphatic hydrops. This study aimed to determine the SVV in MD patients during the chronic phase of illness compared to healthy participants. The second aim was to compare the SVV measurement tools: the analog bucket test, digital bucket test, and C-SVV© goggles. The SVV scores differed significantly between MD patients and the control group for the analog bucket test (p < 0.001) and the C-SVV® goggles (p = 0.028), but no significance was shown when using the digital bucket test (p = 0.062). When comparing the analog bucket test and the C-SVV® goggles applying the calculated threshold (1.125° in analog bucket test, 2.5° in C-SVV® goggles), the bucket test showed higher accuracy (bucket test 73.84%, C-SVV® goggles 69.23%). When examining the influence of betahistine on SVV scores, there were no statistically significant differences in both the analog bucket test and C-SVV© goggles. We conclude that SVV test can be used as an additional tool to evaluate utricle function during the chronic phase of MD and that the analog bucket test produces the most reliable results. The intake of betahistine does not influence the perception of SVV.


  • Digital diaphanoscopy of the maxillary sinuses: A revival of optical diagnosis for rhinosinusitis

    by Katharina Stölzel, Agnieszka J. Szczepek, Heidi Olze, Stefan Koß, Olaf Minet, Urszula Zabarylo


  • Sepsis nach elektiver Septumplastik und Nasenmuschelverkleinerung

    by Katharina Stölzel, Lichun Zhang, Tordis Borowski, Heidi Olze, Tim Schroeder, Kai-Uwe Eckardt, Jens Nee

    Ein 20-jähriger adipöser Patient stellte sich im August 2018 in einer auswärtigen Klinik zur Septumplastik und Muschelverkleinerung bei Septumdeviation und Muschelhyperplasie ohne relevante Vorerkrankungen vor. Intraoperativ war keine Antibiotikagabe erfolgt. Postoperativ wurde der Patient zur weiteren Betreuung mit Doyle-Splinten und Gelaspon® auf die Normalstation verlegt. Es war Hochsommer und die Krankenzimmertemperatur bei ausgefallener Klimaanlage sehr hoch. Wie erst später fremdanamnestisch bekannt wurde, hatte der Patient eine bereits vor stationärer Aufnahme mehrere Tage bestehende, aber nicht mitgeteilte Enteritis. Am Morgen des ersten postoperativen Tages wies der Patient Zeichen der Sepsis auf: arterielle Hypotonie, Tachykardie, Tachypnoe und Desorientierung (= quick Sepsis – related organ failure assessment Score [qSOFA Score] = positiv). Es erfolgte die Gabe von Kristalloiden und bei Schwellung des Gesichtes die Entfernung der Doyle-Splinte. Ungeachtet dessen kam es zur progredienten Verschlechterung und Entwicklung eines schweren Schocks, so dass mit der Gabe von Vasopressoren begonnen wurde. Bei zusätzlich beginnender respiratorischer Erschöpfung wurde die Indikation zur Intubation gestellt. Während der Intubation kam es zur Aspiration. Zur weiteren intensivmedizinischen Versorgung erfolgte aus kapazitären Gründen die Verlegung auf die interdisziplinäre internistische Intensivstation unserer Klinik mit zunächst unklarem Infektfokus. Bei Übernahme war der Patient intubiert und beatmet (CPAP PEEP 9 mbar, Druckunterstützung 16 mbar, FiO2 0,8) und hoch katecholaminpflichtig (Noradrenalin 1 µg/kg/min, Epinephrin 0,2 µg/kg/min).

  • Open Access

    Comorbid Symptoms Occurring During Acute Low-Tone Hearing Loss (AHLH) as Potential Predictors of Menière's Disease

    by Katharina Stölzel, Judith Droste, Linda Josephine Voß, Heidi Olze, Agnieszka J. Szczepek

    Acute low-tone sensorineural hearing loss (ALHL) is a type of idiopathic sudden sensorineural hearing loss. ALHL is rarely a solitary condition but rather co-occurs with vertigo and tinnitus, being an element of contemporary diagnostic criteria for Menière's disease (MD). The goal of our present study was to determine the value of ALHL for the early diagnosis of MD in patients presenting in the emergency room with ALHL as a main complaint. The files of 106 patients with ALHL who were admitted to the emergency room over the period of 7 years and 104 patients with acute high- tone sensorineural hearing loss (AHHL) from the same period were included in this retrospective study. Forty ALHL patients presented with recurrent episode of hearing loss and 66 remaining patients presented with ALHL for the first time. Of the latter group, 25 patients gave consent for the follow-up. First, we analyzed the difference in the occurrence of tinnitus and vertigo between the ALHL and AHHL groups. In patients with ALHL, the incidence of vertigo with tinnitus and the number of recurrent episodes were statistically higher than in patients with AHHL. Next, we focused on the ALHL follow-up group (25 patients). In that group, two patients had all MD symptoms at presentation, 18 had ALHL and tinnitus and five ALHL only. Of 18 patients with ALHL and tinnitus at admission, five developed vertigo and thus the triad of Menière's disease. None of the five patients with AHLH as a sole symptom developed MD during the follow-up time but four of them have developed tinnitus. Patients with recurrent ALHL had significantly higher incidence of MD than the patients with first episode. We conclude that some patients who present with ALHL and concomitant tinnitus or have recurrent episodes of ALHL are more likely to develop Menière's disease than these patients, who present with ALHL as a sole symptom. Nonetheless, we recommend otological follow-up for all patients presenting with ALHL.


  • Effects of surgical treatment of hypertrophic turbinates on the nasal obstruction and the quality of life

    by Katharina Stölzel, Marie Bandelier, Agnieszka J. Szczepek, Heidi Olze, Steffen Dommerich


  • PLLA scaffolds produced by thermally induced phase separation (TIPS) allow human chondrocyte growth and extracellular matrix formation dependent on pore size

    by Gioacchino Conoscenti, Tobias Schneider, Katharina Stoelzel, Francesco Carfì Pavia, Valerio Brucato, Clemens Goegele, Vincenzo La Carrubba, Gundula Schulze-Tanzil


  • Open Access

    Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck

    by Korinna Jöhrens, Ioannis Anagnostopoulos, Steffen Dommerich, Jan Dirk Raguse, Agnieszka J. Szczepek, Frederick Klauschen, Katharina Stölzel

    The receptor for hyaluronan-mediated motility CD168 is associated with the processes of oncogenesis and metastasis. The objective of the present study was to determine the possible association between the expression and distribution of CD168 and the tumor stage of head-and-neck squamous cell carcinoma (SCC). Formalin-fixed and paraffin-embedded tumor samples obtained from 100 patients during primary resection of SCC from the oral cavity, oropharynx, hypopharynx or larynx were included in the present study. The patients were divided into two risk groups: Low risk, representing the early stage of completely resected SCCs with good-to-moderate differentiation, and the high-risk group, representing the advanced stage SCCs with positive resection margins, vascular invasion or locoregional metastasis. All specimens were stained with a monoclonal antibody against CD168. Percentage and staining intensity of CD168-positive cells were scored, and their spatial distribution within the tumor nests was noted. The results obtained were correlated with the tumor stage. The quantification of CD168 expression revealed significant differences between the two risk groups (t-test, P=0.002), with higher scores in tumors resected from the high-risk SSC group compared with those from the low-risk group. In addition, in the high-risk group, the CD168-positive cells were present predominantly in the periphery (70.4%) of tumor nests, whereas in the low-risk group, only 56.6% were located there; however, this trend did not reach the level of statistical significance. Taken together, the results from the present study suggested that CD168 expression patterns could potentially be used as a predictor of tumor aggressiveness, and therefore they may be a prognostic factor in head-and-neck SCC.